MDCM
ZBH icon

Morgan Dempsey Capital Management’s Zimmer Biomet ZBH Stock Holding History

Morgan Dempsey Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-361
Closed -$48K – 145
2020
Q3 		$48K Buy
361
+116
+47% +$15.2K 0.02% 88
2020
Q2 		$28K Buy
+245
New +$28.2K 0.01% 123

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Morgan Dempsey Capital Management's ZBH Position: Q4 2020 in Review

Morgan Dempsey Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 361 shares — an estimated $48K sold.

Morgan Dempsey Capital Management first reported a position in ZBH in Q2 2020 and held it in 2 quarters. The position peaked at $48K in Q3 2020. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

  • Morgan Dempsey Capital Management reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
  • Morgan Dempsey Capital Management sold 361 Zimmer Biomet shares in Q4 2020, an estimated $48K.
  • Morgan Dempsey Capital Management first reported a position in Zimmer Biomet in Q2 2020 and held it in 2 quarters.
  • Morgan Dempsey Capital Management's Zimmer Biomet position peaked at $48K in Q3 2020.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Morgan Dempsey Capital Management's 13F filing for Q4 2020, filed 10 Feb 2021.